The coordinated reduction of numerous genes involved in lipid metabolism (Fig 4A) in the liver in 3 wk old Csf1rko rats is the reciprocal of the increase observed following CSF1 treatment of neonates [28] and likely contributes to both the progressive steatosis and the lack of visceral adipose in the animals. The gene discussed is CSF1; the disease is steatosis.